These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 27930582

  • 1. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
    Sans L, Pascual J, Radosevic A, Quintian C, Ble M, Molina L, Mojal S, Ballarin JA, Torra R, Fernández-Llama P.
    Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
    [Abstract] [Full Text] [Related]

  • 2. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
    Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ.
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):479-86. PubMed ID: 22344503
    [Abstract] [Full Text] [Related]

  • 3. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.
    Sans L, Radosevic A, Quintian C, Montañés R, Gràcia S, Vilaplana C, Mojal S, Ballarin JA, Fernández-Llama P, Torra R, Pascual J.
    PLoS One; 2017 Mar; 12(3):e0174583. PubMed ID: 28346513
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular complications in autosomal dominant polycystic kidney disease.
    Ecder T.
    Curr Hypertens Rev; 2013 Feb; 9(1):2-11. PubMed ID: 23971638
    [Abstract] [Full Text] [Related]

  • 5. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL, Cadnapaphornchai MA, Chonchol MB, Schrier RW, Gitomer B.
    Am J Nephrol; 2016 Feb; 44(3):171-8. PubMed ID: 27548646
    [Abstract] [Full Text] [Related]

  • 6. Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.
    Lai S, Petramala L, Mastroluca D, Petraglia E, Di Gaeta A, Indino E, Panebianco V, Ciccariello M, Shahabadi HH, Galani A, Letizia C, D'Angelo AR.
    Medicine (Baltimore); 2016 Jul; 95(29):e4175. PubMed ID: 27442639
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.
    Ecder T, Schrier RW.
    Nat Rev Nephrol; 2009 Apr; 5(4):221-8. PubMed ID: 19322187
    [Abstract] [Full Text] [Related]

  • 8. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW.
    J Am Soc Nephrol; 1997 Aug; 8(8):1292-7. PubMed ID: 9259356
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.
    Gorriz JL, Arroyo D, D'Marco L, Torra R, Tomás P, Puchades MJ, Panizo N, Pantoja J, Montomoli M, Llisterri JL, Pallares-Carratalá V, Valdivielso JM.
    BMC Nephrol; 2021 Mar 25; 22(1):110. PubMed ID: 33765945
    [Abstract] [Full Text] [Related]

  • 10. Prospective change in renal volume and function in children with ADPKD.
    Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW.
    Clin J Am Soc Nephrol; 2009 Apr 25; 4(4):820-9. PubMed ID: 19346430
    [Abstract] [Full Text] [Related]

  • 11. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Yu ASL, Shen C, Landsittel DP, Harris PC, Torres VE, Mrug M, Bae KT, Grantham JJ, Rahbari-Oskoui FF, Flessner MF, Bennett WM, Chapman AB, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).
    Kidney Int; 2018 Mar 25; 93(3):691-699. PubMed ID: 29290310
    [Abstract] [Full Text] [Related]

  • 12. Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan.
    Higashihara E, Horie S, Muto S, Kawano H, Tambo M, Yamaguchi T, Taguchi S, Kaname S, Yokoyama K, Yoshioka T, Furukawa T, Fukuhara H.
    Am J Nephrol; 2020 Mar 25; 51(11):881-890. PubMed ID: 33227802
    [Abstract] [Full Text] [Related]

  • 13. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL, Meijer E, Visser FW, Engels GE, Kappert P, Losekoot M, Peters DJM, Gansevoort RT, on behalf of the DIPAK-1 study investigators.
    Am J Nephrol; 2019 Mar 25; 50(5):375-385. PubMed ID: 31600749
    [Abstract] [Full Text] [Related]

  • 14. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC, Kang AY, Jang JY, Kim H, Han M, Oh KH, Kim SH, Noh JW, Cheong HI, Hwang YH, Ahn C.
    BMC Nephrol; 2015 Jun 20; 16():86. PubMed ID: 26092580
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review.
    Pietrzak-Nowacka M, Safranow K, Płońska-Gościniak E, Nowacki A, Późniak P, Gutowski P, Ciechanowski K.
    Kidney Blood Press Res; 2024 Jun 20; 49(1):9-19. PubMed ID: 38096797
    [Abstract] [Full Text] [Related]

  • 16. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
    Kidney Int; 2003 Sep 20; 64(3):1035-45. PubMed ID: 12911554
    [Abstract] [Full Text] [Related]

  • 17. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T, Vondrichová H, Strízová J, Sikut M, Janda J, Schärer K.
    Cas Lek Cesk; 1999 Mar 15; 138(6):178-84. PubMed ID: 10510532
    [Abstract] [Full Text] [Related]

  • 18. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.
    Heffernan KS, Kuvin JT, Sarnak MJ, Perrone RD, Miskulin DC, Rudym D, Chandra P, Karas RH, Menon V.
    Nephrol Dial Transplant; 2011 Aug 15; 26(8):2515-21. PubMed ID: 21292815
    [Abstract] [Full Text] [Related]

  • 19. Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).
    Cadnapaphornchai MA.
    Curr Hypertens Rev; 2013 Feb 15; 9(1):21-6. PubMed ID: 23971640
    [Abstract] [Full Text] [Related]

  • 20. KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD Results.
    Griffin BR, You Z, Noureddine L, Gitomer B, Perrenoud L, Wang W, Chonchol M, Jalal D, the HALT Investigators.
    Am J Nephrol; 2020 Feb 15; 51(6):473-479. PubMed ID: 32541154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.